An interesting mix of businesses in the second cohort. EMD punching above its own weight and today's ann confirms the validity of the RWE model. Nice to see FDA also using Palantir in this way.
EMD Price at posting:
21.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
